Medication info
Civtbig Tablet (Memantine Hydrochloride)

Civtbig Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
Oval-shaped film-coated tablet, light yellow to yellow
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003112 · Approved 2020.04.28 · Insurance code 647303910

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (days 1~7): Administer 5mg once daily for 7 days. Week 2 (days 8~14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15~21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years and above is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose titration schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is advisable not to administer this medicine.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps improve memory decline and cognitive function in patients, enhancing the quality of daily life. Regular use can slow down symptom deterioration. Therefore, it is recommended as an effective treatment for patients with moderate to severe Alzheimer's disease.

How to take

Adult dose

1. Adults Dose titration: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (days 1~7): Administer 5mg once daily for 7 days. Week 2 (days 8~14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15~21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose for older patients aged 65 years and above is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose titration schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is advisable not to administer this medicine.

Precautions

This medication should not be administered to certain patients. Firstly, patients who are allergic to the ingredients of this medication should not use it. Additionally, patients with severely impaired liver function or severely reduced kidney function should also refrain from taking this medication. Since this medication contains lactose, patients who have a genetic disorder that prevents them from digesting lactose should not take it. There are patients who require caution when using this medication. Patients with epilepsy or those who have experienced seizures in the past, as well as those with a constitution prone to seizures, should use this medication with caution. Furthermore, taking this medication together with other drugs that have similar effects may increase central nervous system side effects, so it is best not to combine them. Patients with changes in urine acidity should also be monitored carefully. Patients with recent heart disease or uncontrolled hypertension should be cautious when using this medication. This medication may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension. Most side effects are mild to moderate, while severe side effects are rare but still require caution. Neurological symptoms such as mental confusion, hallucinations, and seizures have also been reported. This medication can interact with other drugs. In particular, taking it together with NMDA antagonists or certain nervous system drugs that have similar effects may increase the risk of side effects. Additionally, it may enhance or diminish the effect of some medications, so patients currently taking other drugs should definitely consult a doctor or pharmacist. Pregnant women should refrain from using this medication as its safety has not been established, and it is advisable not to use it unless there is a clear necessity. Lactating women should discontinue breastfeeding when taking this medication as it may be transmitted through breast milk. It is advisable not to use this medication in children or adolescents under 18, as its safety and efficacy have not been confirmed for this age group. In cases of overdose, symptoms such as confusion, drowsiness, dizziness, and vomiting may occur, and in severe cases, consciousness disturbance or seizures may occur. If an overdose is suspected, consult a medical institution immediately for appropriate treatment. This medication may affect the speed of patient responses, so special caution is necessary when driving or operating machinery. Finally, this medication should be stored out of reach of children, and transferring it to another container is not recommended as it may adversely affect its quality.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reaction
Show 24 more
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • venous thromboembolism/thrombosis
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to prevent air or moisture ingress. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Oval-shaped film-coated tablet, light yellow to yellow

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.